Graves SA[Author] - Search Results

Year	Number of Results
1974	2
1975	1
1976	1
1978	1
1980	2
1983	2
1985	5
1990	1
1994	1
1997	1
1998	1
2001	1
2003	2
2004	1
2014	1
2015	14
2016	15
2017	8
2018	3
2019	2
2020	3
2021	8
2022	8
2023	0

1

Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab.

England CG, Ehlerding EB, Hernandez R, Rekoske BT, Graves SA, Sun H, Liu G, McNeel DG, Barnhart TE, Cai W. England CG, et al. Among authors: graves sa. J Nucl Med. 2017 Jan;58(1):162-168. doi: 10.2967/jnumed.116.177857. Epub 2016 Aug 4. J Nucl Med. 2017. PMID: 27493273 Free PMC article.

2

Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer.

Plichta KA, Graves SA, Buatti JM. Plichta KA, et al. Among authors: graves sa. Int J Mol Sci. 2021 Nov 9;22(22):12095. doi: 10.3390/ijms222212095. Int J Mol Sci. 2021. PMID: 34829977 Free PMC article. Review.

3

Dosimetry for Optimized, Personalized Radiopharmaceutical Therapy.

Graves SA, Hobbs RF. Graves SA, et al. Semin Radiat Oncol. 2021 Jan;31(1):37-44. doi: 10.1016/j.semradonc.2020.07.008. Semin Radiat Oncol. 2021. PMID: 33246635 Review.

4

Radiopharmaceutical Chemistry and Drug Development-What's Changed?

Kunos CA, Mankoff DA, Schultz MK, Graves SA, Pryma DA. Kunos CA, et al. Among authors: graves sa. Semin Radiat Oncol. 2021 Jan;31(1):3-11. doi: 10.1016/j.semradonc.2020.07.006. Semin Radiat Oncol. 2021. PMID: 33246634 Free PMC article. Review.

5

SIR-Spheres Activity Measurements Reveal Systematic Miscalibration.

Graves SA, Martin M, Tiwari A, Merrick M, Sunderland J. Graves SA, et al. J Nucl Med. 2022 Aug;63(8):1131-1135. doi: 10.2967/jnumed.121.262650. Epub 2022 Jan 6. J Nucl Med. 2022. PMID: 34992155

6

Half-life of ⁵¹Mn.

Graves SA, Ellison PA, Valdovinos HF, Barnhart TE, Nickles RJ, Engle JW. Graves SA, et al. Phys Rev C. 2017 Jul;96(1):014613. doi: 10.1103/physrevc.96.014613. Epub 2017 Jul 18. Phys Rev C. 2017. PMID: 34327291 Free PMC article.

7

The Impact of Radiopharmaceutical Therapy on Renal Function.

Park EA, Graves SA, Menda Y. Park EA, et al. Among authors: graves sa. Semin Nucl Med. 2022 Jul;52(4):467-474. doi: 10.1053/j.semnuclmed.2022.02.004. Epub 2022 Mar 18. Semin Nucl Med. 2022. PMID: 35314056 Review.

8

Basics of Physics and Radiobiology for Radiopharmaceutical Therapies.

English KK, Knox S, Graves SA, Kiess AP. English KK, et al. Among authors: graves sa. Pract Radiat Oncol. 2022 Jul-Aug;12(4):289-293. doi: 10.1016/j.prro.2022.04.004. Pract Radiat Oncol. 2022. PMID: 35717042 No abstract available.

9

Imaging and dosimetric characteristics of ⁶⁷ Cu.

Merrick MJ, Rotsch DA, Tiwari A, Nolen J, Brossard T, Song J, Wadas TJ, Sunderland JJ, Graves SA. Merrick MJ, et al. Among authors: graves sa. Phys Med Biol. 2021 Jan 26;66(3):035002. doi: 10.1088/1361-6560/abca52. Phys Med Biol. 2021. PMID: 33496267

10

Reply: Single-Time-Point Tumor Dosimetry Assuming Normal Distribution of Tumor Kinetics.

Sgouros G, Dewaraja YK, Escorcia F, Graves SA, Hope TA, Iravani A, Pandit-Taskar N, Saboury B, James SS, Zanzonico PB. Sgouros G, et al. Among authors: graves sa. J Nucl Med. 2022 May;63(5):804. doi: 10.2967/jnumed.121.263717. Epub 2022 Mar 10. J Nucl Med. 2022. PMID: 35273095 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results